Tweets: ANAB ()

chart

AmericanBanking via Twitter 03:40 PM  08/15/18 reply  |  re-tweet

JMP Securities Analysts Give AnaptysBio $ANAB (Msgs, Twts) a $153.00 Price Target https://t.co/3B3L6wRfXX #stocks

registrarjourn via Twitter 03:35 PM  08/15/18 reply  |  re-tweet

AnaptysBio $ANAB (Msgs, Twts) Posts Quarterly Earnings Results, Beats Expectations By $0.13 EPS https://t.co/a6JON8V0wy

EnterpriseLeade via Twitter 03:35 PM  08/15/18 reply  |  re-tweet

AnaptysBio $ANAB (Msgs, Twts) Posts Quarterly Earnings Results, Beats Expectations By $0.13 EPS https://t.co/96p1RqrR6a

TickerReport via Twitter 10:45 AM  08/15/18 reply  |  re-tweet

JMP Securities Reiterates “$153.00” Price Target for AnaptysBio $ANAB (Msgs, Twts) https://t.co/RlSzsW1n5M

WatchlistN via Twitter 10:43 AM  08/15/18 reply  |  re-tweet

JMP Securities Reiterates “$153.00” Price Target for AnaptysBio $ANAB (Msgs, Twts) https://t.co/YNm0iX8DXD

west_moreland via Twitter 10:29 AM  08/15/18 reply  |  re-tweet

89.76 % to Target, JMP Securities Reaffirms ‘Market Outperform’ Rating on AnaptysBio $ANAB (Msgs, Twts) Shares Today https://t.co/R5vxUcniW2

bbnsnews via Twitter 08:57 AM  08/15/18 reply  |  re-tweet

Equities Analysts Offer Predictions for AnaptysBio Inc’s Q3 2018 Earnings $ANAB (Msgs, Twts) https://t.co/VWyZyq3CA1

stocknewsdotcom via Twitter 08:46 AM  08/15/18 reply  |  re-tweet

$ANAB (Msgs, Twts) JMP Securities sets PT at $153 https://t.co/mby4mgu25O

OptionsHawk via Twitter 07:56 AM  08/15/18 reply  |  re-tweet

RT @tgtxdough: JMP $ANAB (Msgs, Twts) Data Preview and Model Update Incorporating POS Ahead of Asthma Readout Market Outperform | Price Target: $153.00…

Bigapple2la via Twitter 07:24 AM  08/15/18 reply  |  re-tweet

Lots of clinical data in the next 6 weeks: $ESPR (Msgs, Twts) $ANAB (Msgs, Twts) $OMER (Msgs, Twts) $FOMX (Msgs, Twts) $VKTX (Msgs, Twts) $GLPG (Msgs, Twts) https://t.co/8BiXC4h8wQ

BIOTECH888 via Twitter 07:12 AM  08/15/18 reply  |  re-tweet

RT @tgtxdough: JMP $ANAB (Msgs, Twts) Data Preview and Model Update Incorporating POS Ahead of Asthma Readout Market Outperform | Price Target: $153.00…

bbnsnews via Twitter 07:10 AM  08/15/18 reply  |  re-tweet

AnaptysBio $ANAB (Msgs, Twts) Lowered to Hold at Zacks Investment Research https://t.co/vvUIWaa9vV

RobbieUSANL via Twitter 06:04 AM  08/15/18 reply  |  re-tweet

RT @tgtxdough: JMP $ANAB (Msgs, Twts) Data Preview and Model Update Incorporating POS Ahead of Asthma Readout Market Outperform | Price Target: $153.00…

tgtxdough via Twitter 05:39 AM  08/15/18 reply  |  re-tweet

JMP $ANAB (Msgs, Twts) Data Preview and Model Update Incorporating POS Ahead of Asthma Readout Market Outperform | Price Target… https://t.co/NB4IlSHxtz

TranscriptDaily via Twitter 05:11 AM  08/15/18 reply  |  re-tweet

AnaptysBio $ANAB (Msgs, Twts) Raised to Buy at Zacks Investment Research https://t.co/LdTXhZMRKY

registrarjourn via Twitter 11:54 PM  08/14/18 reply  |  re-tweet

AnaptysBio $ANAB (Msgs, Twts) Receiving Somewhat Favorable Media Coverage, Study Shows https://t.co/g9g6bQRLz5

EnterpriseLeade via Twitter 11:54 PM  08/14/18 reply  |  re-tweet

AnaptysBio $ANAB (Msgs, Twts) Receiving Somewhat Favorable Media Coverage, Study Shows https://t.co/4k81ACwxci

AlgoSniffer via Twitter 09:38 AM  08/10/18 reply  |  re-tweet

$OLED (Msgs, Twts) big $$$ $ANAB (Msgs, Twts) opened at 81.33 broke thru 82.33 for a successful #BullishBuck Still waiting on $AGIO (Msgs, Twts)!

AlgoSniffer via Twitter 09:06 AM  08/10/18 reply  |  re-tweet

3 #BullishBucks this morning! $AGIO (Msgs, Twts) $OLED (Msgs, Twts) continue to remain. $ANAB (Msgs, Twts) is a new one added to the mix.

geotfar via Twitter 04:18 PM  08/08/18 reply  |  re-tweet

RT @bio_clouseau: $ANAB (Msgs, Twts) shutting down self sponsored peanut allergy trials citing commercial viability $AIMT (Msgs, Twts) $DBVT (Msgs, Twts)

JohnParksAB via Twitter 12:07 AM  08/08/18 reply  |  re-tweet

RT @bio_clouseau: $ANAB (Msgs, Twts) shutting down self sponsored peanut allergy trials citing commercial viability $AIMT (Msgs, Twts) $DBVT (Msgs, Twts)

JohnParksAB via Twitter 12:07 AM  08/08/18 reply  |  re-tweet

$ANAB (Msgs, Twts) stopped their pursuit in peanut allergies. $AIMT (Msgs, Twts) has less competition. $DBVT (Msgs, Twts) remains, but efficacy doesn’t compare.

TradersFish via Twitter 04:34 PM  08/07/18 reply  |  re-tweet

#Biotech data for Q3 has been badly so far, but what about these? $AMRN (Msgs, Twts) $TGTX (Msgs, Twts) $ALNY (Msgs, Twts) $OMER (Msgs, Twts) $ARNA (Msgs, Twts) $ANAB (Msgs, Twts) $OCUL (Msgs, Twts)… https://t.co/IGtWPz74NZ

RandySchreck via Twitter 10:35 AM  08/07/18 reply  |  re-tweet

RT @bio_clouseau: $ANAB (Msgs, Twts) shutting down self sponsored peanut allergy trials citing commercial viability $AIMT (Msgs, Twts) $DBVT (Msgs, Twts)

BayAreaBiotechI via Twitter 08:06 AM  08/07/18 reply  |  re-tweet

RT @bio_clouseau: $ANAB (Msgs, Twts) shutting down self sponsored peanut allergy trials citing commercial viability $AIMT (Msgs, Twts) $DBVT (Msgs, Twts)

Top Searches Feeds

StockTalk Aggregated Feed (includes All Daily and Weekly Editions) Add to My Yahoo! Add to Google
Top Searches Today - 10 (10 hottest stocks) Add to My Yahoo! Add to Google
Web BuZZ Today - 10 (10 hottest stocks) Add to My Yahoo! Add to Google
Twitter BuZZ Today - 10 (10 hottest stocks) Add to My Yahoo! Add to Google
140 close
You will be redirected to the Twitter's authorization page to approve the BoardCentral to connect to your Twitter account. After your approval, the tweet you have entered will be posted.
Out